
The ADAPT-sepsis trial: Biomarker-Guided Antibiotic Duration in Sepsis
💡Disclaimer: This article summarizes the findings of the ADAPT trial, published in the Journale of american medical association (JAMA). For the complete study details, including methodology and results, please refer to the original publication: Biomarker-Guided Antibiotic Duration for Hospitalized Patients With Suspected Sepsis: The ADAPT-Sepsis Randomized Clinical Trial. JAMA. 2024